Synthetic Imine Resveratrol Analog 2-Methoxyl-3,6-Dihydroxyl-IRA Ameliorates Colitis by Activating Protective Nrf2 Pathway and Inhibiting NLRP3 Expression
Open Access
- 21 November 2019
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-13
Abstract
Resveratrol (RSV) is a naturally occurring polyphenol that exhibits pleiotropic health benefits, including anticolitis and colon cancer-protective activity. Recently, we identified the novel imine RSV analog (IRA), 2-methoxyl-3,6-dihydroxyl-IRA 3,4,5,4-tetramethoxystilbene (C33), as a putative activator of nuclear factor erythroid 2-related factor 2 (Nrf2). The present study was designed to evaluate the ability of C33 to activate the Nrf2 signaling pathway and its anticolitis effect in comparison to RSV. The anticolitis action of C33 was assessed in a mouse model of colitis induced by dextran sulfate sodium (DSS). The effect of C33 on the Nrf2 signaling pathway was examined in vitro and in vivo. Compared to RSV, C33 triggered a more dramatic increase in the expression of genes downstream of Nrf2 in LS174T cells as well as in the small intestine and colon of wild-type (WT) mice. Correlated with its superior ability to activate the cytoprotective Nrf2 pathway, C33 was significantly better in ameliorating DSS-induced colitis by improving the inflammation score, as well as downregulating the markers of inflammation in WT mice. Moreover, induction of the NOD-like receptors family pyrin domain containing 3 (NLRP3) inflammasome by colitis was also significantly inhibited by the IRA. Nrf2 knockout completely abolished the effects of C33, indicating that Nrf2 is the important mechanistic target of C33 in vivo. In conclusion, the novel IRA, C33, has stronger anticolitis effects than RSV. Further studies are warranted to evaluate C33 as a potential therapeutic agent for inflammatory bowel disease and cancer chemoprevention.Keywords
Funding Information
- National Natural Science Foundation of China (91643110, 31971188, 31571476)
- National Natural Science Foundation of China (91643110, 31971188, 31571476)
- National Natural Science Foundation of China (91643110, 31971188, 31571476)
This publication has 60 references indexed in Scilit:
- Inflammasome in Intestinal Inflammation and CancerMediators of Inflammation, 2013
- Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugsFree Radical Biology and Medicine, 2011
- Antioxidant and Anti-Inflammatory Effects of Resveratrol in Airway DiseaseAntioxidants & Redox Signaling, 2010
- trans-Resveratrol Inhibits Hyperglycemia-Induced Inflammation and Connexin Downregulation in Retinal Pigment Epithelial CellsJournal of Agricultural and Food Chemistry, 2010
- 2,3′,4,4′,5′‐Pentamethoxy‐trans‐stilbene, a resveratrol derivative, inhibits colitis‐associated colorectal carcinogenesis in miceBritish Journal of Pharmacology, 2010
- Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasomeGut, 2010
- Resveratrol Suppresses Colitis and Colon Cancer Associated with ColitisCancer Prevention Research, 2010
- Increased Susceptibility of Nrf2 Knockout Mice to Colitis-Associated Colorectal CancerCancer Prevention Research, 2008
- Nrf2-Deficient Mice Have an Increased Susceptibility to Dextran Sulfate Sodium–Induced ColitisCancer Research, 2006
- Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from GrapesScience, 1997